Exercise Training for Cardiovascular Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how exercise can improve heart health in individuals with both obesity and type 2 diabetes. Researchers believe exercise may reduce harmful effects on blood vessels caused by substances released from fat tissue. Participants will either follow a standard healthy lifestyle or engage in regular aerobic exercise sessions. Suitable candidates for this trial have obesity (BMI of 35 or more), manage their diabetes with medication or have high fasting glucose levels, and can safely participate in a moderate exercise program. As an unphased trial, this study offers a unique opportunity to contribute to understanding the benefits of exercise on heart health.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the trial involves exercise training, you should consult with your doctor to ensure your medications are compatible with the exercise program.
What prior data suggests that exercise training is safe for cardiovascular health?
Research has shown that regular exercise is generally safe and beneficial for heart health. One study found that people who exercise regularly have a lower risk of dying from any cause. Another study confirmed that moderate exercise, such as brisk walking for 30 minutes a day, helps maintain heart health and is safe. Additionally, people with heart conditions often benefit from structured exercise programs.
In short, exercise is widely accepted as a safe way to prevent and manage heart disease. It can lower risks and improve overall health without major negative effects.12345Why are researchers excited about this trial?
Researchers are excited about exercise training for cardiovascular disease because it offers a non-pharmaceutical approach to improving heart health. Unlike standard treatments like medications or surgical interventions, this method focuses on enhancing cardiovascular function through aerobic exercise. It's unique because it harnesses the body's natural ability to strengthen the heart and blood vessels through regular physical activity. This approach not only aims to improve heart efficiency but also promotes overall well-being and lifestyle changes, which can have long-term benefits beyond what traditional treatments offer.
What evidence suggests that exercise training could be an effective treatment for cardiovascular disease?
Research has shown that regular exercise is crucial for reducing the risk of heart disease. In this trial, participants in the exercise training arm will engage in aerobic exercise for 12 weeks, three times per week, with each session lasting 60 minutes. Studies have found that exercise can lower the risk of dying from heart problems by about 26%. Regular activity helps maintain heart health and can also manage obesity and type II diabetes, both linked to heart disease. Exercise improves blood vessel function and reduces harmful effects from substances released by body fat. Overall, staying active is key to maintaining heart health and lowering the risk of heart issues.13456
Who Is on the Research Team?
Abeer M Mohamed, MD, PhD
Principal Investigator
University of Illinois at Chicago
Are You a Good Fit for This Trial?
This trial is for adults aged 18-50 with obesity (BMI ≥ 35 kg/m2) and type II diabetes, who are not pregnant, can exercise moderately, and have no chronic heart, liver, kidney diseases or cancer. Smokers, drug/alcohol abusers, non-English speakers and those allergic to lidocaine cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Exercise Training
Participants undergo aerobic exercise training for 12 weeks, 3 times per week, 60 minutes per session
Follow-up
Participants are monitored for safety and effectiveness after treatment
Metabolic Surgery
Participants may undergo metabolic surgery to examine changes in adiposome/caveolae axis and their association with vascular function
What Are the Treatments Tested in This Trial?
Interventions
- Exercise training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator